Episode 2: Evolution of Testing in Ovarian Cancer

Evolution of the Care of Patients With Advanced Ovarian CancerПодробнее

Testing for BRCA and HRD in Ovarian CancerПодробнее

Understanding Genetic Mutations and Biomarkers in Ovarian CancerПодробнее

New ovarian cancer testПодробнее

Making Reproductive Longevity a Reality | Episode 1Подробнее

Evaluating the interchangeability of HRD testing in ovarian cancerПодробнее

ACTG Dinner Symposium Highlights | Beyond BRCA testing – does HRD matter? | Prof Michael FriedlanderПодробнее

Genetic Testing in Early and Recurrent Ovarian Cancer | 2022 Evolution ConferenceПодробнее

Potential of Genetic Testing Beyond BRCA1/2 in Ovarian CancerПодробнее

Optimal Testing Methods in Ovarian CancerПодробнее

Ovarian Cancer GeneticsПодробнее

Case 2: Newly Diagnosed Ovarian Cancer, gBRCA-MutatedПодробнее

Potential Risks of Genetic Testing in Ovarian CancerПодробнее

Dr. Lewin on the Importance of BRCA Testing in Ovarian CancerПодробнее

Genetic testing in ovarian cancer clinical study - Target Ovarian CancerПодробнее

Diagnosis and self help for ovarian cancerПодробнее

Detecting Somatic BRCA1/2 Mutations in Ovarian CancerПодробнее

Introduction: Molecular Testing in Ovarian CancerПодробнее

Dr. Rana on Genetic Testing Guidelines for Patients With Ovarian CancerПодробнее

Patient education: Ovarian cancer testingПодробнее